CoChat

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Short-term antidepressant treatment has long-lasting effects, and reverses stress-induced decreases in bone features in rats

Open access

Abstract

Antidepressants are among the most-prescribed class of drugs in the world and though weight gain is a common outcome of antidepressant treatment, that effect is not well understood. We employed an animal model comprised of 2 weeks of chronic restraint stress with antidepressant treatment, followed by diet-induced obesity. We showed that short-term antidepressant treatment had long-lasting effects, not only leading to weight gain, but also enhancing trabecular and cortical bone features in rats; therefore, weight gain in this model was different from that of the classic diet-induced obesity. Late in the post-restraint recovery period, antidepressant-treated animals were significantly heavier and had better bone features than saline-treated controls, when assessed in the distal femoral metaphysis. The propensity to gain weight might have influenced the rate of catch-up growth and bone allometry, as heavier animals treated with fluoxetine also had enhanced bone features when compared to non-stressed animals. Therefore, short-term antidepressant treatment ameliorated the long-term effects of stress on body growth and bone. Growth and bone structural features were associated with leptin levels, and the interaction between leptin levels and antidepressant was significant for bone mineral content, suggesting that short-term antidepressants in the context of long-term diet-induced obesity modified the role of leptin in bone formation. To our knowledge this is the first study reporting that short-term antidepressant treatment has long-lasting effects in restoring the effects of chronic stress in body weight and bone formation. Our findings may be relevant to the understanding and treatment of osteoporosis, a condition of increasing prevalence due to the aging population.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41398-018-0351-z

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 The effect of chronic restraint stress (CRS) and antidepressant on long-term weight gain and effect on classified subgroups of obesity prone (OP) and obesity resistant (OR) groups a Body weight for all groups during experimental days 3 to 296. CRS occurred in the CS (control CRS treated with saline, N = 10), FX (CRS treated with fluxotine, N = 14), and IM (CRS treated with imipramine, N = 13) groups between experimental days 5–19 (grey shaded area, CRS + antidepressant treatment, AD), followed by a high-fat diet from experimental days 19–296. b–d The graph represents the comparison of the difference in body weight [body weight of antidepressant-treated group (FX, N = 14 and IM, N = 13)—non-restraint reference group (NR, N = 30)] in reference to difference in body weight of the restraint saline-treated control group [body weight of saline-treated control group (CS, N = 10)—non-restraint reference group (NR = 30)]. CRS occurred in the CS, FX, and IM groups between experimental days 5–19 (grey shaded area), followed by a high-fat diet from experimental days 19–296. (B) Difference in body weight of all groups, c difference in body weight of OP subgroups, (D) difference in body weight of OR subgroups. *P < 0.05, **P < 0.01, ***P < 0.001
Fig. 1 The effect of chronic restraint stress (CRS) and antidepressant on long-term weight gain and effect on classified subgroups of obesity prone (OP) and obesity resistant (OR) groups a Body weight for all groups during experimental days 3 to 296. CRS occurred in the CS (control CRS treated with saline, N = 10), FX (CRS treated with fluxotine, N = 14), and IM (CRS treated with imipramine, N = 13) groups between experimental days 5–19 (grey shaded area, CRS + antidepressant treatment, AD), followed by a high-fat diet from experimental days 19–296. b–d The graph represents the comparison of the difference in body weight [body weight of antidepressant-treated group (FX, N = 14 and IM, N = 13)—non-restraint reference group (NR, N = 30)] in reference to difference in body weight of the restraint saline-treated control group [body weight of saline-treated control group (CS, N = 10)—non-restraint reference group (NR = 30)]. CRS occurred in the CS, FX, and IM groups between experimental days 5–19 (grey shaded area), followed by a high-fat diet from experimental days 19–296. (B) Difference in body weight of all groups, c difference in body weight of OP subgroups, (D) difference in body weight of OR subgroups. *P < 0.05, **P < 0.01, ***P < 0.001CC BY · PubMed Central
Fig. 2 Interaction between exposure to chronic restraint stress (CRS), short-term antidepressant treatment and high-fat diet, and effects on anxiety and locomotor activity during the post-restraint stress period a Locomotor activity in the open field. (CD/TD) ratio in the openfield box during 30 min of locomotor activity testing; CS, CRS treated with saline, N = 11; FX, CRS treated with fluxotine, N = 14, and IM, CRS treated with imipramine, N = 11. b, c Elevated plus maze. b Time spent in open arm to closed arm ratio. c Number of entries into open arm. CS, N = 11; FX, N = 12; IM, N = 11. Results are shown as means ± s.e.m. *P < 0.05
Fig. 2 Interaction between exposure to chronic restraint stress (CRS), short-term antidepressant treatment and high-fat diet, and effects on anxiety and locomotor activity during the post-restraint stress period a Locomotor activity in the open field. (CD/TD) ratio in the openfield box during 30 min of locomotor activity testing; CS, CRS treated with saline, N = 11; FX, CRS treated with fluxotine, N = 14, and IM, CRS treated with imipramine, N = 11. b, c Elevated plus maze. b Time spent in open arm to closed arm ratio. c Number of entries into open arm. CS, N = 11; FX, N = 12; IM, N = 11. Results are shown as means ± s.e.m. *P < 0.05CC BY · PubMed Central
Fig. 3 Effect of chronic restraint stress (CRS) and antidepressants on femoral bone morphology, and insulin-like growth factor 1 (IGF1) and growth hormone (GH) measurements during post-stress acclimation period a–d Trabecular bone analysis: a micro-computed tomography (CT) images of trabecular and cortical bones, b trabecular bone volume/total volume %, BV/TV %, c trabecular thickness, d trabecular number. e, f Cortical bone analysis: e mean total cross sectional bone area and f bone cross sectional thickness obtained from micro-CT analysis. CS, CRS treated with saline, N = 10; FX, CRS treated with flouxetine, N = 14, and IM CRS treated with imipramine, N = 13, groups. NR, non-CRS reference group, N = 28. g Femur length CS (n = 10), FX (n = 14), IM (n = 13), NR (n = 29). h Comparison of mean Igf1/Gapdh gene expression between treatments, CS, N = 9; FX, N = 12; IM, N = 13; NR, N = 25. i IGF1 plasma concentration (ng/mL), CS, N = 7; FX, N = 8; IM, N = 8; NR, N = 16. j GH pituitary concentration (mg/mL), CS, N = 6; FX, N = 7; IM, N = 6; NR, N = 10. Results are shown as means ± s.e.m. *P < 0.05, **P < 0.01, ***P < 0.001
Fig. 3 Effect of chronic restraint stress (CRS) and antidepressants on femoral bone morphology, and insulin-like growth factor 1 (IGF1) and growth hormone (GH) measurements during post-stress acclimation period a–d Trabecular bone analysis: a micro-computed tomography (CT) images of trabecular and cortical bones, b trabecular bone volume/total volume %, BV/TV %, c trabecular thickness, d trabecular number. e, f Cortical bone analysis: e mean total cross sectional bone area and f bone cross sectional thickness obtained from micro-CT analysis. CS, CRS treated with saline, N = 10; FX, CRS treated with flouxetine, N = 14, and IM CRS treated with imipramine, N = 13, groups. NR, non-CRS reference group, N = 28. g Femur length CS (n = 10), FX (n = 14), IM (n = 13), NR (n = 29). h Comparison of mean Igf1/Gapdh gene expression between treatments, CS, N = 9; FX, N = 12; IM, N = 13; NR, N = 25. i IGF1 plasma concentration (ng/mL), CS, N = 7; FX, N = 8; IM, N = 8; NR, N = 16. j GH pituitary concentration (mg/mL), CS, N = 6; FX, N = 7; IM, N = 6; NR, N = 10. Results are shown as means ± s.e.m. *P < 0.05, **P < 0.01, ***P < 0.001CC BY · PubMed Central
Fig. 4 The effect of chronic restraint stress (CRS) and antidepressant on body weight and composition during post-stress acclimation period a Body weight of OP animals on day 296. b Accumulated food intake in obesity prone animals. CS, CRS treated with saline N = 5; FX, CRS treated with fluxotine, N = 7, and IM, CRS treated with imipramine, N = 7, groups. NR, non-CRS reference group, N = 15. c–g DXA (Dual energy x-ray absorptiometry scan) data for OP animals prior to euthanasia. c Lean mass, d fat mass, e bone mineral density, f bone mineral content, and g body length, CS, N = 4; FX, N = 5; IM, N = 4; NR, N = 10. H Femur length, CS, N = 10; FX, N = 14; IM, N = 13; NR, N = 29. i Plasma leptin level, CS, N = 5; FX, N = 7; IM, N = 7; NR N = 15. Results are shown as means ± s.e.m. *P < 0.05, **P < 0.01, ***P < 0.001
Fig. 4 The effect of chronic restraint stress (CRS) and antidepressant on body weight and composition during post-stress acclimation period a Body weight of OP animals on day 296. b Accumulated food intake in obesity prone animals. CS, CRS treated with saline N = 5; FX, CRS treated with fluxotine, N = 7, and IM, CRS treated with imipramine, N = 7, groups. NR, non-CRS reference group, N = 15. c–g DXA (Dual energy x-ray absorptiometry scan) data for OP animals prior to euthanasia. c Lean mass, d fat mass, e bone mineral density, f bone mineral content, and g body length, CS, N = 4; FX, N = 5; IM, N = 4; NR, N = 10. H Femur length, CS, N = 10; FX, N = 14; IM, N = 13; NR, N = 29. i Plasma leptin level, CS, N = 5; FX, N = 7; IM, N = 7; NR N = 15. Results are shown as means ± s.e.m. *P < 0.05, **P < 0.01, ***P < 0.001CC BY · PubMed Central
Fig. 5 Associations between leptin and body composition outcomes a BMC, bone mineral content; b BMD, bone mineral density; c fat percentage; d BL, body length; e body weight. NR = non-restraint control group, N = 30; CS = chronic restraint stress (CRS) group treated with saline, N = 8; AntiD = CRS + antidepressant-treated group, N = 17. f–h The interaction between leptin and BMC with its treatment outcomes; f leptin levels were strongly associated with BMC in the fluoxetine- (FX) and imipramine- (IM) treated animals; leptin levels were not signifincantly associated in the g CS group and in the h NR group. AntiD = includes FX and IM
Fig. 5 Associations between leptin and body composition outcomes a BMC, bone mineral content; b BMD, bone mineral density; c fat percentage; d BL, body length; e body weight. NR = non-restraint control group, N = 30; CS = chronic restraint stress (CRS) group treated with saline, N = 8; AntiD = CRS + antidepressant-treated group, N = 17. f–h The interaction between leptin and BMC with its treatment outcomes; f leptin levels were strongly associated with BMC in the fluoxetine- (FX) and imipramine- (IM) treated animals; leptin levels were not signifincantly associated in the g CS group and in the h NR group. AntiD = includes FX and IMCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Research works printed but not linked: 1

  1. American Medical Association (AMA). Recognition of obesity as a disease. Contract No.: AMA Health Policy H-440.842 (2013). https://policysearch.ama-assn.org/policyfinder/detail/H-440.842?utrl=%2FAMADoc%2FHOD.xml-0-38-58.xml.

Cited by

See all 12

Metadata

Authors
Lee, S. H., Mastronardi, C. A., Li, R. W., Paz-Filho, G., Dutcher, E. G., Lewis, M. D., Vincent, A. D., Smith, P. N., Bornstein, S. R., Licinio, J., & Wong, M. L.
Affiliations
  • Australian National University (AU)
  • South Australian Health and Medical Research Institute (AU)
  • Flinders University (AU)
  • Freemasons Foundation Centre for Men's Health (AU)
  • University Hospital Carl Gustav Carus (DE)
Corresponding author
  • Licinio, J.
  • Wong, M. L.
Venue
Translational Psychiatry
Published
2019-01-16
Volume
9
Issue
1
Pages
10-10
ISSN
2158-3188 (ISSN-L)
OpenAlex
W2909867320
Cited by
12
References
48
Citations by year
2026: 1 · 2024: 1 · 2022: 1 · 2021: 4 · 2020: 4 · 2019: 1
FWCI
2.65
Type
journal article
Language
en
Open access
Licence
Locations
  • Translational Psychiatry (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by)
  • ANU Open Research (Australian National University) (submittedVersion, cc-by)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
  • South Australian Health and Medical Research Institute
  • Australian National University
  • Flinders University
  • Medical Research Council
  • National Health and Medical Research Council (1070935)
Topics
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
Keywords
antidepressants, fluoxetine, chronic restraint stress, diet-induced obesity, weight gain, bone formation, trabecular bone, cortical bone, catch-up growth, leptin, bone mineral content, osteoporosis
MeSH terms
Animals, Antidepressive Agents, Behavior, Animal, Disease Models, Animal, Fluoxetine, Male, Obesity, Stress, Psychological, Weight Gain, Bone Density, Rats, Sprague-Dawley, Leptin, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Short-term antidepressant treatment has long-lasting effects, and reverses stress-induced decreases in bone features in rats. https://app.cochat.ai/papers/10.1038/s41398-018-0351-z
The paper
Lee, S. H., Mastronardi, C. A., Li, R. W., Paz-Filho, G., Dutcher, E. G., Lewis, M. D., Vincent, A. D., Smith, P. N., Bornstein, S. R., Licinio, J., & Wong, M. L. (2019). Short-term antidepressant treatment has long-lasting effects, and reverses stress-induced decreases in bone features in rats. Translational Psychiatry. https://doi.org/10.1038/s41398-018-0351-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.